Menu

Recent Interviews

Stephan Dorfmeister, Finance Department, Deep Nature Project GmbH

Stephan Dorfmeister
Finance Department | Deep Nature Project GmbH
Untere Hauptstraße 168, 7122 Gols (AT)

office@deep-nature.at

+43 681 10139055

Like Aurora Cannabis and Canopy Growth, Deep Nature Project GmbH focuses on value chain


Alison Coutts, Executive Chairman, Memphasys Ltd.

Alison Coutts
Executive Chairman | Memphasys Ltd.
30 Richmond Road, 2140 Homebush West (AUS)

alison.coutts@memphasys.com

+61 2 8415 7300

Memphasys Executive Chairman Alison Coutts on in vitro fertilisation (IVF)


Thomas Soltau, CEO, wallstreet:online capital AG

Thomas Soltau
CEO | wallstreet:online capital AG
Michaelkirchstraße 17/18, 10179 Berlin (D)

service@smartbroker.de

+49 30 27 57 76 464

Smartbroker - wallstreet:online capital AG CEO Thomas Soltau in an interview on the market launch


16. April 2020 | 07:55 CET

Johnson & Johnson, Memphasys, Procter & Gamble - for a better life

  • Health

Good health is a valuable possession. Small and large companies around the globe are engaged in research and development to make people's lives easier or better through modern and innovative products and solutions. The consumer goods and pharmaceutical sectors often offer attractive opportunities for investors to generate a lucrative return. Well-known companies with established brands usually ensure lasting sales. However, promising young companies also use innovations to attract the attention of investors and customers.

time to read: 1 minutes by Mario Hose


 

Innovation helps with the desire for children

Memphasys from Australia deals with the subject of in-vitro fertilization. The target groups are couples who wish to have children but have not yet been able to achieve a successful pregnancy by natural means. The company has developed a product called FELIX, which is used in the field of bio-separation of sperm. With this innovation, the particularly promising sperm cells are separated from the seminal fluid in just a few minutes to increase the chances of a successful pregnancy. Initially, the focus is on artificial insemination of humans, but in the future animals will also be accompanied.

Alison Coutts is Executive Chairman of Memphasys and explains the product and future areas of application in a video - youtu.be/kHA-UhbeZH8. FELIX is expected to be launched in the second half of 2020. The company currently has a market capitalization of around AUD 35 million and a successful market launch offers corresponding potential for the shares.

Group with brands

Johnson & Johnson is a broad-based group from the USA and is a member of the Dow Jones Index. The market value of the company is around USD 390 billion. Johnson & Johnson products are available under various brands worldwide and can be found in virtually every household. The pharmaceutical and consumer goods manufacturer has a highly diversified product universe and can therefore benefit from a variety of revenue streams. Optimal conditions for conservative investors.

Dividend stock with consumer goods

Procter & Gamble is also a member of the Dow Jones Index and has a market capitalization of approximately USD 300 billion. The manufacturer of consumer goods can also offer a wide range of products from around the world on the shelves of drugstores and supermarkets. The company aims to improve the lives of its customers with products in the Care, Hygiene, Healthcare and Household segments. Due to the size of the company and the diversity of its product range, the dividend stock can build on numerous revenue streams and drive development.


Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold shares in the aforementioned companies and that there may therefore be a conflict of interest. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

14. May 2020 | 13:11 CET

BioNTech, EXMceuticals, Shop Apotheke Europe, Symrise - Shares gaining momentum

  • Health

The easing of measures to contain the Corona Pandemic will be further extended and, in parallel, companies and their employees will be able to increase personal communications again. However, the curfew phase was also used for strategic decisions and developments, as investors can see from announcements in recent weeks. The situation represents a crisis for many people, but it is also an opportunity for change and a new beginning. Market participants have learned in recent months that dependence on China leads to many bottlenecks and global diversification is therefore necessary. Anyone who wants to be part of it must have the right shares in their portfolio.

Read

15. April 2020 | 08:10 CET

BioNTech, Evotec, EXMceuticals - Stocks with potential

  • Health

Health is the most important thing in life. The current protective measures around the globe in connection with the spread of the Corona Virus Covid-19 show how great the fear and helplessness is. Above all, this pandemic has highlighted the extent of the global dependence on China as a supplier of medicines or medical ingredients and protective clothing. Supply chains will get shorter. Individuals and societies will be more focused on health and wellness. In view of the time after the current Corona Crisis it is expected that politics and the economy will reorganize and reposition themselves.

Read

17. January 2020 | 13:37 CET

Evotec, Memphasys, MorphoSys - Growth Industry Health

  • Health

He who is healthy has many desires, he who is ill only one. Companies around the globe deal with diseases and special features of nature in order to treat or cure them. In addition to the widespread disease of cancer, there are also topics that are less talked about, but are also a big market. Developments can be of great importance for investors, physicians and the people affected. It can therefore be worthwhile to deal with the variety of topics.

Read